Inhibitory signals to the host immune system produced by the interaction between PD-1 ligands (PD-L1 or PD-L2) expressed on cancer cells and PD-1 on T-lymphocytes allow cancer cells to avoid host immune surveillance [1]. Here, CD274 is linked to cancer.